P.L. Almasio

445 total citations
27 papers, 344 citations indexed

About

P.L. Almasio is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, P.L. Almasio has authored 27 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 16 papers in Hepatology and 5 papers in Rheumatology. Recurrent topics in P.L. Almasio's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (12 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). P.L. Almasio is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (12 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). P.L. Almasio collaborates with scholars based in Italy, Austria and United Kingdom. P.L. Almasio's co-authors include Antonio Craxı̀, Evangelista Sagnelli, Andrea Mele, V. Di Marco, Michele Imparato, Tommaso Stroffolini, R. Di Stefano, Oreste Lo Iacono, S. Magrin and Calogero Cammà and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Urology and Journal of Hepatology.

In The Last Decade

P.L. Almasio

25 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.L. Almasio Italy 9 246 228 53 50 27 27 344
WY Chang Taiwan 10 278 1.1× 267 1.2× 14 0.3× 18 0.4× 71 2.6× 10 409
Jacqueline So China 9 44 0.2× 131 0.6× 70 1.3× 29 0.6× 19 0.7× 18 237
Yushu Shang China 8 219 0.9× 143 0.6× 4 0.1× 23 0.5× 63 2.3× 10 369
Suut Göktürk Türkiye 11 141 0.6× 196 0.9× 7 0.1× 11 0.2× 29 1.1× 31 303
Magdy El‐Serafy Egypt 10 354 1.4× 312 1.4× 18 0.3× 4 0.1× 11 0.4× 39 438
G. Hatzis Greece 11 312 1.3× 287 1.3× 25 0.5× 8 0.2× 18 0.7× 25 376
Monica Arenas-Hernandez United Kingdom 9 29 0.1× 54 0.2× 18 0.3× 28 0.6× 41 1.5× 13 311
Giulia Frontini Italy 11 67 0.3× 36 0.2× 214 4.0× 32 0.6× 10 0.4× 20 279
Kazuhiko Yamauchi Japan 7 95 0.4× 86 0.4× 16 0.3× 8 0.2× 38 1.4× 18 188
Mohammed Shatat Egypt 10 260 1.1× 294 1.3× 42 0.8× 7 0.1× 27 1.0× 16 364

Countries citing papers authored by P.L. Almasio

Since Specialization
Citations

This map shows the geographic impact of P.L. Almasio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.L. Almasio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.L. Almasio more than expected).

Fields of papers citing papers by P.L. Almasio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.L. Almasio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.L. Almasio. The network helps show where P.L. Almasio may publish in the future.

Co-authorship network of co-authors of P.L. Almasio

This figure shows the co-authorship network connecting the top 25 collaborators of P.L. Almasio. A scholar is included among the top collaborators of P.L. Almasio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.L. Almasio. P.L. Almasio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morreale, Gaetano Cristian, et al.. (2016). OC.12.2 HLA TESTING IN ADULT-ONSET CELIAC DESEASE: RELATIONSHIP WITH CLINICAL PRESENTATION AND MUCOSAL DAMAGE. Digestive and Liver Disease. 48. e115–e115. 1 indexed citations
2.
Simone, F., Vincenza Calvaruso, R. Orlando, et al.. (2014). Effectiveness of beta-blocker in primary prevention of variceal bleeding in patients with cirrhosis: A prospective evaluation by hepatic venous pressure gradient measurement. Digestive and Liver Disease. 46. e141–e141. 1 indexed citations
3.
Licata, Anna, et al.. (2013). 539 DRUG-INDUCED LIVER INUJRY: THE IMPACT OF NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs). Journal of Hepatology. 58. S220–S221. 1 indexed citations
4.
Licata, Anna, Michael Cappello, Vincenza Calvaruso, et al.. (2011). 497 PATTERN OF DRUG-INDUCED LIVER INJURY: THE IMPACT OF AMOXICILLIN-CLAVULANATE ON SEVERITY OF CLINICAL COURSE. Journal of Hepatology. 54. S203–S203. 1 indexed citations
5.
Cappello, Michael, et al.. (2011). P.1.221: SERUM LIPID ALTERATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH TNF ALPHA ANTAGONISTS. Digestive and Liver Disease. 43. S221–S221. 1 indexed citations
6.
Cappello, Michael, et al.. (2011). P.1.124: DISEASE EXTENTION IS THE MAJOR PROGNOSTIC FACTOR OF CLINICAL COURSE IN PATIENTS WITH ULCERATIVE COLITIS. Digestive and Liver Disease. 43. S189–S189. 1 indexed citations
7.
Tarantino, Giuseppe, V. Di Marco, Salvatore Petta, et al.. (2009). Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection. Journal of Viral Hepatitis. 16(6). 397–405. 16 indexed citations
8.
Sagnelli, Evangelista, Tommaso Stroffolini, Andrea Mele, Michele Imparato, & P.L. Almasio. (2008). Chronic Hepatitis B in Italy: New Features of an Old Disease--Approaching the Universal Prevalence of Hepatitis B e Antigen--Negative Cases and the Eradication of Hepatitis D Infection. Clinical Infectious Diseases. 46(1). 110–113. 49 indexed citations
9.
Stroffolini, Tommaso, Guido Colloredo, G.B. Gaeta, et al.. (2004). Does an ‘autoimmune’ profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. Journal of Viral Hepatitis. 11(3). 257–262. 40 indexed citations
10.
Pavone, Carlo, et al.. (2004). PROSPECTIVE, RANDOMIZED, CROSSOVER COMPARISON OF SUBLINGUAL APOMORPHINE (3 mg) WITH ORAL SILDENAFIL (50 mg) FOR MALE ERECTILE DYSFUNCTION. The Journal of Urology. 172(6 Part 1). 2347–2349. 16 indexed citations
11.
Stroffolini, T., Evangelista Sagnelli, P.L. Almasio, et al.. (2003). Characteristics of liver cirrhosis in Italy: results from a multicenter national study. Digestive and Liver Disease. 36(1). 56–60. 32 indexed citations
12.
Attanasio, Massimo, et al.. (2003). Long-term interferon-β treatment for multiple sclerosis. Neurological Sciences. 24(5). 361–364. 44 indexed citations
13.
Almasio, P.L., Giovanna Venezia, & Antonio Craxı̀. (2003). The impact of antiviral therapy on the course of chronic HCV infection. A systematic review.. PubMed. 45(3). 175–82. 6 indexed citations
14.
Marco, V. Di, Donatella Ferraro, P.L. Almasio, et al.. (2002). Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high‐dose interferon induction. Journal of Viral Hepatitis. 9(5). 354–359. 15 indexed citations
15.
Cammà, Calogero, V. Di Marco, Oreste Lo Iacono, et al.. (1998). Long-term course of interferon-treated chronic hepatitis C. Journal of Hepatology. 28(4). 531–537. 67 indexed citations
16.
Albertí, A., P.L. Almasio, Antonio Ascione, et al.. (1997). Guidelines for the treatment of chronic viral hepatitis. 29(6). 597–600. 4 indexed citations
17.
Craxı̀, Antonio, V. Di Marco, Calogero Cammà, P.L. Almasio, & S. Magrin. (1996). Duration of HCV infection as a predictor of nonresponse to interferon. Digestive Diseases and Sciences. 41(S12). 86S–92S. 8 indexed citations
18.
Almasio, P.L., Giampaolo Bianchi, Giulio Marchesini, et al.. (1994). Sulphur amino acid pattern in chronic liver disease.. PubMed. 26(1). 21–5. 8 indexed citations
19.
Craxı̀, Antonio, V. Di Marco, P.L. Almasio, et al.. (1993). The natural history of chronic HDV infection.. PubMed. 382. 301–10. 5 indexed citations
20.
Marco, V. Di, Oreste Lo Iacono, Stefania La Grutta, et al.. (1993). alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia.. PubMed. 77(6). 502–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by WY Chang Breakdown of academic impact, for papers by Jacqueline So Breakdown of academic impact, for papers by Yushu Shang Breakdown of academic impact, for papers by Suut Göktürk Breakdown of academic impact, for papers by Magdy El‐Serafy Breakdown of academic impact, for papers by G. Hatzis Breakdown of academic impact, for papers by Monica Arenas-Hernandez Breakdown of academic impact, for papers by Giulia Frontini Breakdown of academic impact, for papers by Kazuhiko Yamauchi Breakdown of academic impact, for papers by Mohammed Shatat
Rankless by CCL
2026